FYR Diagnostics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$8M
- Investors
-
6
FYR Diagnostics General Information
Description
Developer of a multi-omic profiling platform designed to decode RNA and protein signals in blood. The company's platform utilizes artificial intelligence and proprietary extracellular vesicle enrichment technology to analyze cellular proteins and nucleic acids from peripheral blood samples, enabling biopharma and clinical partners to discover biomarkers, design smarter trials, and monitor treatment response dynamically.
Contact Information
Website
www.fyr.bioCorporate Office
- 1121 East Broadway Street
- Missoula, MT 59802
- United States
Corporate Office
- 1121 East Broadway Street
- Missoula, MT 59802
- United States
FYR Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 24-Sep-2025 | $8M | Completed | Generating Revenue | ||
| 4. Grant | 15-Aug-2021 | Completed | Product Development | |||
| 3. Grant | 10-Oct-2019 | Completed | Product Development | |||
| 2. Seed Round | 01-Jan-2019 | $650K | $650K | Completed | Product Development | |
| 1. Accelerator/Incubator | Completed | Product Development |
FYR Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2C | ||||||||
| Seed-2B | ||||||||
| Seed-2A | 11,210,063 | $0.000010 | 5% | $0.85 | $0.85 | 1x | $0.85 | 18.59% |
| Seed | 1,250,000 | $0.000010 | 5% | $0.52 | $0.52 | 1x | $0.52 | 5.6% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
FYR Diagnostics Patents
FYR Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026178346-A1 | Bias reduction for machine learning feature selection | Pending | 21-Feb-2025 | ||
| WO-2026050159-A1 | Compositions and methods for detection of gene expression | Pending | 26-Aug-2024 |
FYR Diagnostics Signals
FYR Diagnostics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The Sontag Foundation | Limited Partner | Minority | ||
| Yuvaan Tiwari Foundation | Not-For-Profit Venture Capital | Minority | ||
| National Institutes of Health | Government | |||
| National Institutes of Neurological Disorders and Stroke | Government | |||
| Two Bear Capital | Venture Capital | Minority |
FYR Diagnostics FAQs
-
When was FYR Diagnostics founded?
FYR Diagnostics was founded in 2016.
-
Where is FYR Diagnostics headquartered?
FYR Diagnostics is headquartered in Missoula, MT.
-
What is the size of FYR Diagnostics?
FYR Diagnostics has 18 total employees.
-
What industry is FYR Diagnostics in?
FYR Diagnostics’s primary industry is Discovery Tools (Healthcare).
-
Is FYR Diagnostics a private or public company?
FYR Diagnostics is a Private company.
-
What is the current valuation of FYR Diagnostics?
The current valuation of FYR Diagnostics is .
-
What is FYR Diagnostics’s current revenue?
The current revenue for FYR Diagnostics is .
-
How much funding has FYR Diagnostics raised over time?
FYR Diagnostics has raised $8.65M.
-
Who are FYR Diagnostics’s investors?
The Sontag Foundation, Yuvaan Tiwari Foundation, National Institutes of Health, National Institutes of Neurological Disorders and Stroke, and Two Bear Capital are 5 of 6 investors who have invested in FYR Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process